Atlas Venture is an early stage venture capital firm investing in biotech innovation.
Phone: 617-588-2600
25 First Street
Suite 303
Cambridge, 02141
Massachusetts, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-05-18 | Accent Therapeutics | Series A | $40M | EcoR1 Capital, and The Column Group |
| 2018-05-16 | Plastiq | Series D | $27M | Khosla Ventures, and Top Tier Capital Partners |
| 2018-02-01 | Avrobio | Series B | $60M | Aisling Capital, Brace Pharma Capital, Citadel, Clarus, Cormorant Asset Management, Eventide Asseet Management, Morningside Ventures, and SV Health Investors |
| 2018-01-31 | Akriveia Therapeutics | Series B | $3M | F-Prime Capital |
| 2017-12-14 | Kyn Therapeutics | Series A | $49M | OrbiMed Advisors |
